ADENOSINE- adenosine injection, solution 
Cantrell Drug Company

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Adenosine 90 mg/30mL in 0.9% Sodium Chloride 30 mL Syringe

• WARNINGS AND PRECAUTIONS

Outsourced Compounded Drug. Not for Resale. Hospital/Office Use Only.

• ADVERSE EVENTS

To facilitate Adverse Event Reporting: www.fda.gov/medwatch or 1-800-FDA-1088.

• HOW SUPPLIED

Adenosine injection solution is supplied as a sterile, nonpyrogenic, isotonic solution that is clear, colorless at 30 mL in a Single-Dose Syringe.

This product is Preservative-Free and Latex-Free.

• INGREDIENTS

Each 1 mL contains 3 mg adenosine and 9 mg sodium chloride. The aqueous solution is adjusted to a pH of 4.5 - 7.5 with hydrochloric acid and/or sodium hydroxide, if necessary.

• STORAGE AND HANDLING

Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature]. Do not refrigerate as crystallization may occur. If crystallization has occurred, dissolve crystals by warming to room temperature. The solution must be clear at the time of use.

• DOSAGE AND ADMINISTRATION.

FOR INTRAVENOUS USE ONLY. PRESERVATIVE-FREE INJECTION SOLUTION.

Rx Only


Rev. 02/15


CANTRELL DRUG COMPANY

LITTLE ROCK, AR 72207

image description

ADENOSINE 
adenosine injection, solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:52533-236
Route of AdministrationINTRAVENOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) ADENOSINE3 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X) 9 mg  in 1 mL
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:52533-236-0330 mL in 1 SYRINGE, PLASTIC; Type 0: Not a Combination Product02/05/201512/06/2017
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other02/05/201512/06/2017
Labeler - Cantrell Drug Company (035545763)

Revised: 12/2017
Document Id: 5faf28fe-0295-e917-e053-2a91aa0a81b2
Set id: 1ac3b6d9-7e57-4f27-8f78-436a6a55a9be
Version: 2
Effective Time: 20171206
 
Cantrell Drug Company